東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Characterization of human lung tumor...

State University of New York at Buffalo., Microbiology and Immunology.

Linked to FindBook

Google Book

Amazon

博客來

Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells./
Author:	Nazareth, Michael Ralph.
Description:	139 p.
Notes:	Adviser: Richard B. Bankert.
Contained By:	Dissertation Abstracts International69-05B.
Subject:	Biology, Microbiology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3310044
ISBN:	9780549597414

Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells.
Nazareth, Michael Ralph.

Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells. - 139 p.

Adviser: Richard B. Bankert.

Thesis (Ph.D.)--State University of New York at Buffalo, 2008.

The tumor microenvironment of human non-small cell lung cancer (NSCLC) is composed largely of stromal cells, including fibroblasts, yet these cells have been the focus of few studies. Here, we established stromal cell cultures from primary NSCLC through isolation of adherent cells. Characterization of these cells by flow cytometry demonstrated a population which expressed a human fibroblast-specific 112-kd surface molecule, Thy1/CD90, alpha-SMA, and FAP, but failed to express CD45 and CD11b/Mac-1, a phenotype consistent with that of an activated myofibroblast. These cells, referred to here as tumor-associated fibroblasts (TAF), were found to express B7H1 (PD-L1) and B7DC (PD-L2) constitutively on their surface, and this expression was upregulated by IFN-gamma. Several human non-small cell lung tumor cell lines also expressed B7H1 and B7DC, and some also expressed other B7 family co-regulatory molecules such as B7H2 and B7H4. It was also determined that TAF constitutively produce a number of proinflammatory cytokines and chemokines, including IFN-gamma, IFN-beta, MIG, IP-10, RANTES, and TGF-beta1. TAF production of these biologically active factors and expression of regulatory surface molecules, provide multiple opportunities for the TAF to influence cellular interactions within the tumor microenvironment. To evaluate the ability of TAF to modulate tumor-associated T cell (TAT) activation, we conducted co-culture experiments between autologous TAF and TAT. In five out of eight tumors, TAF elicited a contact-dependent enhancement of TAT activation, even in the presence of a TGF-beta1-mediated suppressive effect. The contact-dependent enhancing response is MHC restricted, since the addition of blocking antibodies against MHC Class I or MHC Class II inhibited the TAF-mediated enhancing effect. In the three other tumors, TAF suppressed TAT activation, and, in one of these cases, blockade of B7H1 or B7DC was able to completely reverse the TAF-mediated suppression. This indicates that TAF expression of B7 family co-regulatory molecules is a potential mechanism by which TAF can regulate TAT activation within the tumor microenvironment. We conclude that TAF in human NSCLC provide multiple complex regulatory signals that have the potential to influence TAT quiescence and activation in the human non-small cell lung tumor microenvironment.

ISBN: 9780549597414Subjects--Topical Terms:

1017734
Biology, Microbiology.

Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells.
LDR:03308nam 2200265 a 45 001 858209
005 20100712
008 100712s2008 ||||||||||||||||| ||eng d
020 $a 9780549597414
035 $a (UMI)AAI3310044
035 $a AAI3310044
040 $a UMI $c UMI
100 1 $a Nazareth, Michael Ralph. $3 1025246
245 1 0 $a Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells.
300 $a 139 p.
500 $a Adviser: Richard B. Bankert.
500 $a Source: Dissertation Abstracts International, Volume: 69-05, Section: B, page: 2768.
502 $a Thesis (Ph.D.)--State University of New York at Buffalo, 2008.
520 $a The tumor microenvironment of human non-small cell lung cancer (NSCLC) is composed largely of stromal cells, including fibroblasts, yet these cells have been the focus of few studies. Here, we established stromal cell cultures from primary NSCLC through isolation of adherent cells. Characterization of these cells by flow cytometry demonstrated a population which expressed a human fibroblast-specific 112-kd surface molecule, Thy1/CD90, alpha-SMA, and FAP, but failed to express CD45 and CD11b/Mac-1, a phenotype consistent with that of an activated myofibroblast. These cells, referred to here as tumor-associated fibroblasts (TAF), were found to express B7H1 (PD-L1) and B7DC (PD-L2) constitutively on their surface, and this expression was upregulated by IFN-gamma. Several human non-small cell lung tumor cell lines also expressed B7H1 and B7DC, and some also expressed other B7 family co-regulatory molecules such as B7H2 and B7H4. It was also determined that TAF constitutively produce a number of proinflammatory cytokines and chemokines, including IFN-gamma, IFN-beta, MIG, IP-10, RANTES, and TGF-beta1. TAF production of these biologically active factors and expression of regulatory surface molecules, provide multiple opportunities for the TAF to influence cellular interactions within the tumor microenvironment. To evaluate the ability of TAF to modulate tumor-associated T cell (TAT) activation, we conducted co-culture experiments between autologous TAF and TAT. In five out of eight tumors, TAF elicited a contact-dependent enhancement of TAT activation, even in the presence of a TGF-beta1-mediated suppressive effect. The contact-dependent enhancing response is MHC restricted, since the addition of blocking antibodies against MHC Class I or MHC Class II inhibited the TAF-mediated enhancing effect. In the three other tumors, TAF suppressed TAT activation, and, in one of these cases, blockade of B7H1 or B7DC was able to completely reverse the TAF-mediated suppression. This indicates that TAF expression of B7 family co-regulatory molecules is a potential mechanism by which TAF can regulate TAT activation within the tumor microenvironment. We conclude that TAF in human NSCLC provide multiple complex regulatory signals that have the potential to influence TAT quiescence and activation in the human non-small cell lung tumor microenvironment.
590 $a School code: 0656.
650 4 $a Biology, Microbiology. $3 1017734
690 $a 0410
710 2 $a State University of New York at Buffalo. $b Microbiology and Immunology. $3 1025245
773 0 $t Dissertation Abstracts International $g 69-05B.
790 $a 0656
790 1 0 $a Bankert, Richard B., $e advisor
791 $a Ph.D.
792 $a 2008
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3310044